Suchergebnisse - "Karapanagiotou-Schenkel, Irini"

PubPharm (31)

1

Sickle cell disease in Germany : Results from a national registry

enthalten in: Pediatric blood & cancer | 2020

von Kunz, J. | Lobitz, S. | Grosse, R. | +31

2

Sickle cell disease in Germany : Results from a national registry

enthalten in: Pediatric Blood & Cancer | 2020

von Kunz, J. | Lobitz, S. | Grosse, R. | +30

3

Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia

enthalten in: Clinical epigenetics | 2019

von van Tilburg, C. | Milde, T. | Witt, R. | +24

4

Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia

enthalten in: Clinical epigenetics | 2019

von van Tilburg, C. | Milde, T. | Witt, R. | +24

5

Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia

sonderdruck aus: Clinical epigenetics | 2019

von Tilburg, C. | Milde, T. | Flotho, C. | +2

6

Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia

enthalten in: Clinical epigenetics | 10 December 2019

von Tilburg, C. | Milde, T. | Witt, R. | +24

7

N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma

enthalten in: Neuro-oncology | 2019

von Wick, W. | Dettmer, S. | Berberich, A. | +16

CommentIn: Neuro Oncol. 2019 Jan 1;21(1):6-7. - PMID 30590835

8

Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial

Erschienen: London, BioMed Central, 2016

von Hoffmann, K. | Ganten, T. | Gotthardt, D. | +6

9

Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial

enthalten in: BMC cancer | 2015

von Hoffmann, K. | Ganten, T. | Gotthardtp, D. | +9

10

Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial

enthalten in: BMC cancer | 2015

von Hoffmann, K. | Ganten, T. | Gotthardtp, D. | +9